Showing results (371-380 of 759) with videos related to
Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|July 13, 2023
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trialMan-Fung Yuen, Tarik Asselah, Ira M Jacobson, et al.The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.The Lancet. Gastroenterology & Hepatology|May 14, 2026
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?Virginia Solitano, Vipul Jairath, Fernando Magro, et al.The Lancet. Gastroenterology & Hepatology|July 16, 2026
Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trialRobert Hüneburg, Querijn N E van Bokhorst, Maria Pellisé, et al.The Lancet. Gastroenterology & Hepatology|September 23, 2026
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trialSheraz Yaqub, Morten Valberg, Bjørn Atle Bjørnbeth, et al.The Lancet. Gastroenterology & Hepatology|October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort studyOhad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.The Lancet. Gastroenterology & Hepatology|November 5, 2022
The intestinal barrier in disorders of the central nervous systemCarolina Pellegrini, Matteo Fornai, Vanessa D'Antongiovanni, et al.The Lancet. Gastroenterology & Hepatology|January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort studyOhad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.The Lancet. Gastroenterology & Hepatology|January 19, 2025
Antibiotic treatment versus appendicectomy for acute appendicitis in adults: an individual patient data meta-analysisJochem C G Scheijmans, Jussi Haijanen, David R Flum, et al.The Lancet. Gastroenterology & Hepatology|January 13, 2025
Ramadan intermittent fasting for patients with gastrointestinal and hepatobiliary diseases: practical guidance for health-care professionalsMuhammad Usman, Nasir Javed, Aida Jawhari, et al.Pageof 76